Cite
MLA Citation
Keith A A Fox et al.. “Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA Registry.” European heart journal, vol. 8, no. 8, 2022, pp. 825–836. http://access.bl.uk/ark:/81055/vdc_100171887941.0x00000a